Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Role of Toll-Like Receptors in Hematopoietic Malignancies
Darlene Monlish, Sima Bhatt, Laura G. Schuettpelz
Frontiers in Immunology (2016) Vol. 7
Open Access | Times Cited: 98

Showing 1-25 of 98 citing articles:

Innate immune pathways and inflammation in hematopoietic aging, clonal hematopoiesis, and MDS
Jennifer J. Trowbridge, Daniel T. Starczynowski
The Journal of Experimental Medicine (2021) Vol. 218, Iss. 7
Open Access | Times Cited: 137
Toll-like receptor-guided therapeutic intervention of human cancers: molecular and immunological perspectives
Suprabhat Mukherjee, Ritwik Patra, Payam Behzadi, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 63
Promising Targets for Cancer Immunotherapy: TLRs, RLRs, and STING-Mediated Innate Immune Pathways
Kai Li, Shuai Qu, Xi Chen, et al.
International Journal of Molecular Sciences (2017) Vol. 18, Iss. 2, pp. 404-404
Open Access | Times Cited: 158
Cytokine production in myelofibrosis exhibits differential responsiveness to JAK-STAT, MAP kinase, and NFκB signaling
Daniel A.C. Fisher, Cathrine A. Miner, Elizabeth K. Engle, et al.
Leukemia (2019) Vol. 33, Iss. 8, pp. 1978-1995
Open Access | Times Cited: 124
Inflammatory Signaling Pathways in Preleukemic and Leukemic Stem Cells
Shayda Hemmati, Tamanna Haque, Kira Gritsman
Frontiers in Oncology (2017) Vol. 7
Open Access | Times Cited: 90
Nucleic Acid Sensors as Therapeutic Targets for Human Disease
Sarah M. McWhirter, Caroline A. Jefferies
Immunity (2020) Vol. 53, Iss. 1, pp. 78-97
Open Access | Times Cited: 76
IRAK1 and IRAK4 as emerging therapeutic targets in hematologic malignancies
Joshua Bennett, Daniel T. Starczynowski
Current Opinion in Hematology (2021) Vol. 29, Iss. 1, pp. 8-19
Open Access | Times Cited: 62
Regulation of myelopoiesis by proinflammatory cytokines in infectious diseases
Yukino Chiba, Izuru Mizoguchi, Hideaki Hasegawa, et al.
Cellular and Molecular Life Sciences (2017) Vol. 75, Iss. 8, pp. 1363-1376
Closed Access | Times Cited: 79
Role of Type I and II Interferons in Colorectal Cancer and Melanoma
Simone Di Franco, Alice Turdo, Matilde Todaro, et al.
Frontiers in Immunology (2017) Vol. 8
Open Access | Times Cited: 68
Sepsis-induced AKI: From pathogenesis to therapeutic approaches
Fang-Fang He, Yumei Wang, Yiyuan Chen, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 37
The immune system as a system of relations
Marc Daëron
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 33
Paralog-specific signaling by IRAK1/4 maintains MyD88-independent functions in MDS/AML
Joshua Bennett, Chiharu Ishikawa, Puneet Agarwal, et al.
Blood (2023) Vol. 142, Iss. 11, pp. 989-1007
Open Access | Times Cited: 18
Dual functional roles of the MyD88 signaling in colorectal cancer development
Lu Wang, Kewei Yu, Xiang Zhang, et al.
Biomedicine & Pharmacotherapy (2018) Vol. 107, pp. 177-184
Closed Access | Times Cited: 53
Dysregulation of Cell Survival in Diffuse Large B Cell Lymphoma: Mechanisms and Therapeutic Targets
Yi Miao, L. Jeffrey Medeiros, Zijun Y. Xu‐Monette, et al.
Frontiers in Oncology (2019) Vol. 9
Open Access | Times Cited: 46
Biological and therapeutic implications of a unique subtype of NPM1 mutated AML
Arvind Singh Mer, Emily Heath, Seyed Ali Madani Tonekaboni, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 37
Mechanisms of TLR4-Mediated Autophagy and Nitroxidative Stress
Kunli Zhang, Qiuyan Huang, Shoulong Deng, et al.
Frontiers in Cellular and Infection Microbiology (2021) Vol. 11
Open Access | Times Cited: 37
The role of inflammation in hematopoiesis and bone marrow failure: What can we learn from mouse models?
Jun Wang, Miriam Erlacher, Juncal Fernández‐Orth
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 27
Outdoor artificial light at night, air pollution, and risk of childhood acute lymphoblastic leukemia in the California Linkage Study of Early-Onset Cancers
Charlie Zhong, Rong Wang, Libby M. Morimoto, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 15
Role of innate immunological/inflammatory pathways in myelodysplastic syndromes and AML: a narrative review
Charan Thej Reddy Vegivinti, Praneeth Reddy Keesari, Sindhusha Veeraballi, et al.
Experimental Hematology and Oncology (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 15
IRAK-4 inhibition: emavusertib for the treatment of lymphoid and myeloid malignancies
Ricardo Parrondo, Madiha Iqbal, Reinhard von Roemeling, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 12
TLR2 deficiency is beneficial at the late phase in MPTP-induced Parkinson’ disease mice
Yongtao He, Jiayin Zhao, Hongtian Dong, et al.
Life Sciences (2023) Vol. 333, pp. 122171-122171
Closed Access | Times Cited: 11
Regulation of immune responses to infection through interaction between stem cell-derived exosomes and toll-like receptors mediated by microRNA cargoes
Mehrdad Moosazadeh Moghaddam, Elham Behzadi, Hamid Sedighian, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access | Times Cited: 4
Inflammatory profile of lower risk myelodysplastic syndromes
Joanne Topping, Adele M. Taylor, Fatima Nadat, et al.
British Journal of Haematology (2024) Vol. 205, Iss. 3, pp. 1044-1054
Open Access | Times Cited: 4
Functional Toll-Like Receptors (TLRs) Are Expressed by a Majority of Primary Human Acute Myeloid Leukemia Cells and Inducibility of the TLR Signaling Pathway Is Associated with a More Favorable Phenotype
Annette K. Brenner, Øystein Bruserud
Cancers (2019) Vol. 11, Iss. 7, pp. 973-973
Open Access | Times Cited: 31
Therapeutic targeting of the inflammasome in myeloid malignancies
Samarpana Chakraborty, Lauren C. Shapiro, Sofía de Oliveira, et al.
Blood Cancer Journal (2021) Vol. 11, Iss. 9
Open Access | Times Cited: 26
Page 1 - Next Page

Scroll to top